The Emergence of Retail Health: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the...
What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the...
BCR/ABL1 Testing [Test in Focus] - Insights
David Viswanatha, M.D., a hematopathologist and co-director of the molecular hematology and complete genome sequencing laboratories at Mayo Clinic, provides an overview of BCR/ABL1 testing, discusses the best testing methods, NCCN/ELN...
Expanding Reach Through Home Phlebotomy - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with Camille Jewell, outpatient laboratory service technician at Mayo Clinic. They...
Holiday Specimen Shipment - Insights
Due to the Labor Day holiday (recognized on Monday, September 7), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected.
Viruses and Variants: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi...
Monkeypox and legislation updates: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D....
COVID-19 Update: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi...
Laboratory Innovation: Dr. Bill Morice - Insights
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
Navigating Technology Disruptions: John Osborn - Insights
From cyberattacks to utility failures, technology disruptions are a growing risk in an increasingly digitized and automated laboratory environment. Planning for technology disruptions positions laboratories to embrace the full power of...
Advancements in Autoimmune Neurology: Dr. Andrew McKeon - Insights
Andrew McKeon, M.B., B.Ch., M.D., an expert in neuroimmunology, joins the "Answers From the Lab" podcast for a conversation with Bobbi Pritt, M.D. In this episode, Dr. McKeon and Dr. Pritt discuss how Mayo Clinic is pioneering advancements...
COVID-19 Variants: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this...
People Archives - Page 11 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Reframing diagnosis for peripheral neuropathy - Insights
Learn more about how Mayo Clinic Laboratories’ algorithmic testing approach to peripheral neuropathy cuts through diagnostic complexity to provide meaningful answers.
Mayo Clinic Labs @Work: Daniel Kronemann - Insights
As a clinical laboratory technologist, Daniel Kronemann enjoys going beyond his day-to-day work as he explores new ways to enhance processes and systems in Bacteriology.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Emergency/Overdose - Mayo Clinic Laboratories
Emergency/Overdose This test is intended to manage an apparent overdose, intoxicated patient, or determine if a specific set of symptoms might be due to the presence of drugs. This test is designed...
MCL - Adrenal Mass Panel Patient Information - MC1235-267
MCL - Adrenal Mass Panel Patient Information
Marijuana - Mayo Clinic Laboratories
Marijuana Δ9-Tetrahydrocannabinol (THC) Interpretation The parent drug, Δ9-tetrahydrocannabinol (THC), has a clearance half-life of less than 30 minutes and is not detectable in urine. Following a dose of THC, the...
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 8 - Insights
This week’s Research Roundup highlights radical versus partial nephrectomy for cT1 renal cell carcinoma.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 1 - Insights
This week’s Research Roundup highlights carcinoid heart disease in patients with bronchopulmonary carcinoid.
Mayo Clinic Laboratory and pathology research roundup: September 28 - Insights
This week's research roundup features: Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: A randomized clinical trial.
Creepy, Dreadful, Wonderful Viruses - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Bobbi Pritt, M.D., shares a series of spooky tales to scare and amaze related to the discovery, characterization, and clinical presentation of notable viruses.
Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in the Division of Cardiovascular Diseases, participated in a U.S. Food and Drug Administration meeting about...
At the recent AACC annual scientific meeting, Melissa Snyder, Ph.D., Consultant in the Division of Clinical Biochemistry and Immunology at Mayo Clinic in Rochester, Minnesota, presented the short course, “Clinical and Laboratory Aspects of...
Leslie Donato, Ph.D., DABCC, Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester, recently authored an article in Clinical...
Jeff Meeusen, Ph.D., a clinical chemist and Co-Director of Cardiovascular Laboratory Medicine at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News that discusses patient fasting in lipid testing. While...
Sleep Disorder Testing - Mayo Clinic Laboratories
Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients.
Enhancing Personalized Medicine with Cardiovascular Genomics - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Linnea Baudhuin, Ph.D., professor of laboratory medicine and pathology in the division of laboratory genetics and genomics, discusses inherited cardiovascular conditions and identifies...
International contact information - Insights
Learn how to connect with Mayo Clinic Laboratories to discuss international testing.
Mayo Clinic Laboratories in the UnitedHealthcare Preferred Lab Network - Insights
Mayo Clinic Laboratories is pleased to announce it has been selected as a UnitedHealthcare Preferred Lab Network (PLN) care provider. Under the agreement, effective July 1, 2019, UnitedHealthcare members have in-network access to Mayo...
Autoimmune Neurology Testing - Insights
Autoimmune neurology is a rapidly evolving subspecialty driven by the discovery that the immune system can target virtually any structure within the
Next-generation sequencing - Insights
Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.
Advanced Crohn's monitoring test launched by Mayo Clinic - Insights
Mayo Clinic Laboratories introduces an advancement in the management of Crohn's disease with the release of a new laboratory test that measures Risankizumab levels in patients. This test will advance the therapeutic monitoring of Crohn's...
Looking Back on Clinical Chemistry 1 - Insights
Kylie Reising, a student in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course.
Study can improve understanding of how disability develops in MS - Insights
Mayo Clinic researchers have identified clear differences in brain and spinal cord scarring in patients with demyelinating diseases.
Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score - Insights
Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score.
Mayo Clinic Laboratory and Pathology Research Roundup: April 2 - Insights
This week's research roundup feature: Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma of germinal center origin, which presents with significant biologic and clinical heterogeneity. Using RNA-seq on B cells sorted from 87 FL...
Mayo Clinic Laboratory and Pathology Research Roundup: March 19 - Insights
This week's research roundup feature: The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity with single lineage (MDS-RS-SLD) or...
William Morice, II, M.D., Ph.D., Featured in The Athletic - Insights
Dr. Morice was recently featured in The Athletic regarding sports teams and how to safely and efficiently bring them back.
Protimes, Clotting, and Fibrin-Oh My: A Reflection on Hemostasis - Insights
Reilly Hannon, a student in the Mayo Clinic Medical Laboratory Science program, reflects on her course in hemostasis.
Adapting to Fast-Paced Studying - Insights
Reilly Hannon, a student in the Mayo Clinic Medical Laboratory Science program, discusses valuable study techniques she has learned.
Bobbi Pritt, M.D., Discusses Hookworms with The Washington Post - Insights
The Washington Post recently reported on hookworms burrowing into a teenager's skin during a trip to Florida. Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services at Mayo Clinic,...
Bobbi Pritt, M.D., on Asian Longhorned Tick in U.S - Insights
According to the Centers for Disease Control and Prevention (CDC), the Asian longhorned tick has spread across nine states since it first appeared in the U.S. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and...
CPT codes and LOINC update: March 2024 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of March.
Mayo Clinic Laboratory and Pathology Research Roundup: May 21 - Insights
This week's research roundup feature: Monoclonal immunoglobulin (MIg) crystalline nephropathies are rare lesions resulting from precipitation of MIgs in the kidney as crystalline inclusions. They can be categorized into lesions with...
Innovative Alzheimer's disease diagnostic tool unveiled - Insights
Mayo Clinic Laboratories has marked a significant advancement in the fight against Alzheimer's disease with the introduction of an innovative diagnostic test. This noninvasive blood test accurately detects the p-Tau217 biomarker, indicative...
Mayo Clinic Infectious Disease Study Noted in Clinical Microbiology Newsletter - Insights
An article recently published in the Clinical Microbiology Newsletter made mention of a Mayo Clinic study. The article discussed a topic that has become increasingly popular—self-collected specimens.
Mayo Clinic Laboratory and Pathology Research Roundup: January 30 - Insights
This week's research roundup feature: Incapacitated regulatory T cells (Tregs) contribute to immune-mediated diseases. Inflammatory Tregs are evident during human inflammatory bowel disease (IBD); however, mechanisms driving the development...
Mayo Clinic Laboratory and Pathology Research Roundup: January 23 - Insights
This week's research roundup feature: Measles virus (MV) vaccine strains have shown significant preclinical antitumor activity against glioblastoma (GBM), the most lethal glioma histology. In this first in human trial (NCT00390299), a...